Olmesartan + Indapamide fixed-dose combination

· Brainfarma Industria Química e Farmacêutica S/A

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olmesartan + Indapamide fixed-dose combination, covering 2022-03-21 to 2022-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. [Phase 3]

See pricing